Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depressive Disorder, Major | 151 | 2024 | 4762 | 9.880 |
Why?
|
Antidepressive Agents | 61 | 2024 | 2897 | 5.550 |
Why?
|
S-Adenosylmethionine | 22 | 2019 | 218 | 5.030 |
Why?
|
Hypericum | 14 | 2019 | 58 | 3.710 |
Why?
|
Depression | 64 | 2024 | 8126 | 3.150 |
Why?
|
Citalopram | 11 | 2019 | 402 | 3.090 |
Why?
|
Yoga | 8 | 2024 | 281 | 2.490 |
Why?
|
Eicosapentaenoic Acid | 12 | 2023 | 561 | 2.310 |
Why?
|
Fatty Acids, Omega-3 | 22 | 2023 | 1390 | 2.190 |
Why?
|
Depressive Disorder | 23 | 2024 | 3728 | 2.180 |
Why?
|
Phytotherapy | 10 | 2013 | 296 | 2.040 |
Why?
|
Complementary Therapies | 10 | 2020 | 486 | 1.820 |
Why?
|
Antidepressive Agents, Second-Generation | 16 | 2015 | 489 | 1.780 |
Why?
|
Docosahexaenoic Acids | 10 | 2023 | 907 | 1.710 |
Why?
|
Double-Blind Method | 65 | 2024 | 12341 | 1.570 |
Why?
|
Fluoxetine | 20 | 2012 | 733 | 1.510 |
Why?
|
Suicide, Attempted | 17 | 2021 | 1402 | 1.480 |
Why?
|
Sleep Initiation and Maintenance Disorders | 8 | 2022 | 1081 | 1.470 |
Why?
|
Piperazines | 13 | 2017 | 2523 | 1.410 |
Why?
|
Dietary Supplements | 21 | 2024 | 3415 | 1.360 |
Why?
|
Acupuncture Therapy | 6 | 2015 | 486 | 1.310 |
Why?
|
Sertraline | 4 | 2016 | 209 | 1.290 |
Why?
|
Psychiatric Status Rating Scales | 43 | 2024 | 6019 | 1.240 |
Why?
|
Suicidal Ideation | 17 | 2021 | 1447 | 1.220 |
Why?
|
Plant Extracts | 7 | 2014 | 497 | 1.060 |
Why?
|
Antipsychotic Agents | 11 | 2019 | 3067 | 1.060 |
Why?
|
Folic Acid | 11 | 2016 | 1323 | 1.050 |
Why?
|
Quinolones | 4 | 2013 | 378 | 1.030 |
Why?
|
Ketamine | 6 | 2022 | 519 | 0.970 |
Why?
|
Libido | 4 | 2013 | 119 | 0.940 |
Why?
|
Mental Disorders | 18 | 2023 | 6845 | 0.860 |
Why?
|
Republic of Korea | 23 | 2022 | 590 | 0.820 |
Why?
|
Brain-Derived Neurotrophic Factor | 7 | 2023 | 602 | 0.820 |
Why?
|
Electroacupuncture | 1 | 2022 | 66 | 0.790 |
Why?
|
Treatment Outcome | 83 | 2024 | 64685 | 0.780 |
Why?
|
Interview, Psychological | 3 | 2017 | 809 | 0.770 |
Why?
|
Personality Disorders | 6 | 2020 | 722 | 0.750 |
Why?
|
Dependent Personality Disorder | 1 | 2020 | 13 | 0.740 |
Why?
|
Placebos | 9 | 2019 | 1667 | 0.730 |
Why?
|
Middle Aged | 136 | 2024 | 220921 | 0.710 |
Why?
|
Humans | 265 | 2024 | 761596 | 0.710 |
Why?
|
Lepidium | 2 | 2011 | 8 | 0.700 |
Why?
|
Randomized Controlled Trials as Topic | 19 | 2024 | 10212 | 0.700 |
Why?
|
Adult | 141 | 2024 | 221210 | 0.700 |
Why?
|
Independent Living | 3 | 2021 | 579 | 0.700 |
Why?
|
Female | 178 | 2024 | 392705 | 0.670 |
Why?
|
Sexual Dysfunction, Physiological | 4 | 2013 | 357 | 0.670 |
Why?
|
Mitragyna | 1 | 2019 | 16 | 0.670 |
Why?
|
Male | 165 | 2024 | 360846 | 0.670 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 11 | 2013 | 1988 | 0.630 |
Why?
|
Drug Resistance | 8 | 2013 | 1596 | 0.620 |
Why?
|
Drug Therapy, Combination | 25 | 2020 | 6312 | 0.620 |
Why?
|
Bipolar Disorder | 9 | 2020 | 5092 | 0.620 |
Why?
|
Akathisia, Drug-Induced | 2 | 2017 | 67 | 0.610 |
Why?
|
Psychotic Disorders | 7 | 2020 | 3223 | 0.590 |
Why?
|
Riluzole | 2 | 2019 | 59 | 0.590 |
Why?
|
Cannabidiol | 1 | 2019 | 118 | 0.570 |
Why?
|
Psychiatry | 9 | 2023 | 1693 | 0.560 |
Why?
|
Personality | 1 | 2020 | 554 | 0.560 |
Why?
|
Pilot Projects | 18 | 2023 | 8633 | 0.560 |
Why?
|
Folic Acid Deficiency | 4 | 2009 | 117 | 0.550 |
Why?
|
Thiazoles | 4 | 2017 | 1517 | 0.540 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2017 | 165 | 0.540 |
Why?
|
Military Personnel | 2 | 2019 | 1246 | 0.530 |
Why?
|
Panic Disorder | 4 | 2020 | 613 | 0.530 |
Why?
|
Dose-Response Relationship, Drug | 20 | 2020 | 10766 | 0.510 |
Why?
|
Psychotherapy | 8 | 2020 | 1647 | 0.500 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2020 | 448 | 0.500 |
Why?
|
Dementia | 4 | 2022 | 2689 | 0.490 |
Why?
|
Quality of Life | 9 | 2024 | 13367 | 0.480 |
Why?
|
Anxiety | 13 | 2022 | 4573 | 0.460 |
Why?
|
Naltrexone | 1 | 2016 | 317 | 0.450 |
Why?
|
Hospitals, General | 6 | 2023 | 798 | 0.450 |
Why?
|
Suicide | 8 | 2017 | 1602 | 0.450 |
Why?
|
Plant Preparations | 2 | 2011 | 94 | 0.450 |
Why?
|
Psychological Techniques | 1 | 2013 | 48 | 0.440 |
Why?
|
Behavior, Addictive | 4 | 2021 | 462 | 0.420 |
Why?
|
Carnitine | 1 | 2014 | 252 | 0.420 |
Why?
|
Patient Selection | 3 | 2017 | 4244 | 0.420 |
Why?
|
Hot Temperature | 1 | 2019 | 1440 | 0.410 |
Why?
|
Young Adult | 45 | 2024 | 59260 | 0.410 |
Why?
|
Taurine | 1 | 2012 | 93 | 0.410 |
Why?
|
Histamine | 1 | 2014 | 499 | 0.400 |
Why?
|
Interleukin-6 | 5 | 2024 | 3208 | 0.400 |
Why?
|
Dysthymic Disorder | 1 | 2011 | 75 | 0.380 |
Why?
|
Anger | 5 | 2020 | 406 | 0.370 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2012 | 276 | 0.370 |
Why?
|
Vitamin D | 5 | 2023 | 3303 | 0.370 |
Why?
|
Amnesia | 1 | 2013 | 257 | 0.360 |
Why?
|
Dissociative Disorders | 1 | 2013 | 234 | 0.360 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 211 | 0.360 |
Why?
|
Cholecalciferol | 4 | 2024 | 553 | 0.360 |
Why?
|
Homocysteine | 6 | 2012 | 638 | 0.350 |
Why?
|
Hallucinations | 1 | 2013 | 366 | 0.350 |
Why?
|
Acetylcysteine | 1 | 2011 | 260 | 0.350 |
Why?
|
Sulfones | 1 | 2013 | 448 | 0.350 |
Why?
|
Aged | 59 | 2024 | 169310 | 0.340 |
Why?
|
Seasonal Affective Disorder | 1 | 2009 | 49 | 0.340 |
Why?
|
Academies and Institutes | 1 | 2012 | 318 | 0.330 |
Why?
|
Clinical Trials as Topic | 7 | 2017 | 8002 | 0.330 |
Why?
|
Pregnanolone | 2 | 2020 | 67 | 0.330 |
Why?
|
Electric Stimulation Therapy | 1 | 2015 | 628 | 0.330 |
Why?
|
Telomere | 4 | 2021 | 943 | 0.320 |
Why?
|
Sexual Dysfunctions, Psychological | 3 | 2018 | 189 | 0.320 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2011 | 2751 | 0.310 |
Why?
|
Weight Gain | 3 | 2017 | 2348 | 0.310 |
Why?
|
Depression, Postpartum | 3 | 2022 | 346 | 0.310 |
Why?
|
Anxiety Disorders | 9 | 2021 | 2720 | 0.300 |
Why?
|
Carbonated Beverages | 1 | 2009 | 210 | 0.300 |
Why?
|
Placebo Effect | 2 | 2017 | 518 | 0.300 |
Why?
|
Behavioral Symptoms | 1 | 2010 | 186 | 0.300 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.300 |
Why?
|
Central Nervous System Stimulants | 1 | 2016 | 1177 | 0.300 |
Why?
|
Attitude of Health Personnel | 3 | 2014 | 3889 | 0.290 |
Why?
|
Triazoles | 2 | 2004 | 903 | 0.290 |
Why?
|
Infrared Rays | 2 | 2019 | 247 | 0.290 |
Why?
|
Combined Modality Therapy | 7 | 2018 | 8527 | 0.290 |
Why?
|
Medical History Taking | 1 | 2011 | 774 | 0.290 |
Why?
|
Tetrahydrofolates | 3 | 2012 | 58 | 0.280 |
Why?
|
Students | 2 | 2015 | 1741 | 0.270 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2018 | 625 | 0.270 |
Why?
|
Inflammation | 6 | 2023 | 10774 | 0.270 |
Why?
|
Alcoholism | 2 | 2017 | 1973 | 0.260 |
Why?
|
Sexual Behavior | 3 | 2023 | 2180 | 0.260 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2019 | 4575 | 0.260 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4352 | 0.260 |
Why?
|
Tachyphylaxis | 2 | 2018 | 54 | 0.250 |
Why?
|
Adolescent | 42 | 2024 | 88326 | 0.250 |
Why?
|
Receptors, Interleukin-6 | 2 | 2024 | 225 | 0.250 |
Why?
|
Thiazepines | 2 | 2015 | 30 | 0.240 |
Why?
|
Patients | 1 | 2011 | 907 | 0.240 |
Why?
|
Electrocardiography | 2 | 2022 | 6377 | 0.240 |
Why?
|
Veterans | 1 | 2019 | 2649 | 0.240 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 228 | 0.240 |
Why?
|
Affect | 3 | 2021 | 1486 | 0.240 |
Why?
|
Vitamin B 12 | 5 | 2012 | 524 | 0.240 |
Why?
|
Polymorphism, Genetic | 3 | 2018 | 4243 | 0.240 |
Why?
|
Sex Characteristics | 1 | 2015 | 2639 | 0.240 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 891 | 0.240 |
Why?
|
Food | 1 | 2009 | 774 | 0.240 |
Why?
|
Personality Inventory | 5 | 2019 | 1019 | 0.230 |
Why?
|
Personality Assessment | 3 | 2020 | 650 | 0.230 |
Why?
|
Psychoanalytic Interpretation | 1 | 2004 | 55 | 0.230 |
Why?
|
Ambulatory Care | 3 | 2014 | 2775 | 0.220 |
Why?
|
Bupropion | 3 | 2006 | 304 | 0.220 |
Why?
|
Cross-Cultural Comparison | 3 | 2016 | 635 | 0.220 |
Why?
|
DNA Methylation | 4 | 2023 | 4399 | 0.210 |
Why?
|
Biological Psychiatry | 1 | 2022 | 26 | 0.200 |
Why?
|
Receptors, Dopamine | 1 | 2002 | 296 | 0.200 |
Why?
|
Receptors, Serotonin | 1 | 2002 | 208 | 0.200 |
Why?
|
Obsessive Behavior | 1 | 2021 | 51 | 0.190 |
Why?
|
Vitamins | 5 | 2023 | 1635 | 0.190 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2759 | 0.190 |
Why?
|
Treatment Failure | 3 | 2021 | 2643 | 0.190 |
Why?
|
Hostility | 2 | 2013 | 183 | 0.190 |
Why?
|
Leptin | 3 | 2019 | 1597 | 0.190 |
Why?
|
C-Reactive Protein | 4 | 2023 | 3826 | 0.180 |
Why?
|
Compulsive Behavior | 1 | 2021 | 117 | 0.180 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2020 | 0.180 |
Why?
|
Outpatients | 6 | 2020 | 1597 | 0.180 |
Why?
|
Cognition | 6 | 2024 | 6992 | 0.180 |
Why?
|
Impulsive Behavior | 3 | 2019 | 346 | 0.180 |
Why?
|
Heterosexuality | 1 | 2023 | 309 | 0.180 |
Why?
|
Heating | 1 | 2021 | 104 | 0.180 |
Why?
|
Psychopharmacology | 2 | 2019 | 148 | 0.180 |
Why?
|
Anemia, Macrocytic | 1 | 2000 | 53 | 0.180 |
Why?
|
Paranoid Behavior | 1 | 2019 | 5 | 0.170 |
Why?
|
Menarche | 1 | 2023 | 532 | 0.170 |
Why?
|
Hallucinogens | 1 | 2023 | 197 | 0.170 |
Why?
|
Panic | 1 | 2019 | 103 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2002 | 1122 | 0.170 |
Why?
|
Plant Roots | 2 | 2011 | 117 | 0.170 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 709 | 0.170 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2000 | 118 | 0.160 |
Why?
|
Herpes Simplex | 1 | 2023 | 478 | 0.160 |
Why?
|
Follicular Phase | 1 | 2019 | 143 | 0.160 |
Why?
|
Luteal Phase | 1 | 2019 | 138 | 0.160 |
Why?
|
Sleep | 4 | 2021 | 4768 | 0.160 |
Why?
|
Personal Satisfaction | 2 | 2016 | 644 | 0.160 |
Why?
|
Methionine | 2 | 2012 | 572 | 0.160 |
Why?
|
Sleep, REM | 1 | 2022 | 595 | 0.150 |
Why?
|
Drug Synergism | 4 | 2017 | 1757 | 0.150 |
Why?
|
Analysis of Variance | 6 | 2016 | 6228 | 0.150 |
Why?
|
Thinking | 1 | 2021 | 320 | 0.150 |
Why?
|
Administration, Intranasal | 1 | 2020 | 477 | 0.150 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 865 | 0.150 |
Why?
|
Globus Pallidus | 1 | 2019 | 250 | 0.150 |
Why?
|
Sleep Stages | 1 | 2022 | 694 | 0.150 |
Why?
|
Breathing Exercises | 1 | 2018 | 59 | 0.150 |
Why?
|
Pituitary-Adrenal System | 2 | 2018 | 552 | 0.150 |
Why?
|
Canada | 2 | 2022 | 2122 | 0.150 |
Why?
|
Nutritional Physiological Phenomena | 2 | 2015 | 363 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 27 | 0.140 |
Why?
|
Progesterone | 2 | 2019 | 742 | 0.140 |
Why?
|
Magnetic Resonance Angiography | 1 | 2024 | 1432 | 0.140 |
Why?
|
Comorbidity | 10 | 2018 | 10508 | 0.140 |
Why?
|
Body Weight | 3 | 2022 | 4618 | 0.140 |
Why?
|
Primary Health Care | 6 | 2023 | 4687 | 0.140 |
Why?
|
Tobacco Use Cessation | 1 | 2018 | 94 | 0.140 |
Why?
|
Diet | 3 | 2021 | 8075 | 0.140 |
Why?
|
Psychometrics | 5 | 2022 | 3065 | 0.140 |
Why?
|
Antimanic Agents | 3 | 2020 | 520 | 0.140 |
Why?
|
Cyclohexanols | 2 | 2009 | 126 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2018 | 701 | 0.140 |
Why?
|
Meditation | 3 | 2020 | 251 | 0.140 |
Why?
|
Follow-Up Studies | 15 | 2020 | 39106 | 0.140 |
Why?
|
Time Factors | 11 | 2021 | 39969 | 0.140 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 618 | 0.140 |
Why?
|
Physicians | 1 | 2014 | 4591 | 0.140 |
Why?
|
Nicotinic Agonists | 1 | 2018 | 265 | 0.130 |
Why?
|
Electroconvulsive Therapy | 1 | 2021 | 500 | 0.130 |
Why?
|
Hypochondriasis | 1 | 2016 | 93 | 0.130 |
Why?
|
Secondary Prevention | 3 | 2011 | 1475 | 0.130 |
Why?
|
Bulimia | 1 | 2018 | 400 | 0.130 |
Why?
|
Internship and Residency | 4 | 2020 | 5882 | 0.130 |
Why?
|
Cohort Studies | 9 | 2022 | 41495 | 0.130 |
Why?
|
Thalamus | 2 | 2017 | 1047 | 0.130 |
Why?
|
Paraquat | 1 | 2015 | 32 | 0.130 |
Why?
|
Menopause | 2 | 2023 | 1646 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1844 | 0.130 |
Why?
|
Brain | 5 | 2019 | 27121 | 0.130 |
Why?
|
Cross-Sectional Studies | 12 | 2023 | 26129 | 0.120 |
Why?
|
Aging | 4 | 2023 | 8710 | 0.120 |
Why?
|
Testosterone | 2 | 2020 | 2472 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2007 | 2373 | 0.120 |
Why?
|
Water | 1 | 2021 | 1411 | 0.120 |
Why?
|
Railroads | 1 | 2014 | 63 | 0.120 |
Why?
|
Nerve Net | 2 | 2017 | 2291 | 0.120 |
Why?
|
Prevalence | 7 | 2019 | 15733 | 0.120 |
Why?
|
Video Games | 1 | 2017 | 198 | 0.120 |
Why?
|
Herbicides | 1 | 2015 | 105 | 0.120 |
Why?
|
Prefrontal Cortex | 3 | 2022 | 2220 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2021 | 543 | 0.120 |
Why?
|
Epidermal Growth Factor | 4 | 1995 | 702 | 0.120 |
Why?
|
Triazines | 1 | 2016 | 311 | 0.120 |
Why?
|
Risk Factors | 18 | 2023 | 74213 | 0.120 |
Why?
|
Epigenesis, Genetic | 4 | 2023 | 3801 | 0.110 |
Why?
|
Infusions, Intravenous | 4 | 2022 | 2217 | 0.110 |
Why?
|
Massachusetts | 6 | 2020 | 8833 | 0.110 |
Why?
|
Employment | 1 | 2020 | 1118 | 0.110 |
Why?
|
Leucovorin | 2 | 2009 | 643 | 0.110 |
Why?
|
Psychomotor Agitation | 2 | 2014 | 305 | 0.110 |
Why?
|
Accidents | 1 | 2014 | 165 | 0.110 |
Why?
|
Thyroidectomy | 1 | 2019 | 908 | 0.110 |
Why?
|
Somatoform Disorders | 2 | 2008 | 423 | 0.110 |
Why?
|
United States | 13 | 2022 | 72340 | 0.110 |
Why?
|
Heart Rate | 3 | 2022 | 4195 | 0.110 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 299 | 0.110 |
Why?
|
Nicotine | 1 | 2018 | 680 | 0.110 |
Why?
|
Psychiatric Department, Hospital | 2 | 2007 | 126 | 0.110 |
Why?
|
Disability Evaluation | 1 | 2020 | 1836 | 0.110 |
Why?
|
Remission Induction | 4 | 2016 | 2397 | 0.110 |
Why?
|
Mental Health Services | 2 | 2004 | 1730 | 0.110 |
Why?
|
Transforming Growth Factors | 1 | 1992 | 75 | 0.110 |
Why?
|
Caregivers | 2 | 2022 | 2238 | 0.110 |
Why?
|
Phototherapy | 2 | 2020 | 368 | 0.100 |
Why?
|
Drug Administration Schedule | 5 | 2019 | 4853 | 0.100 |
Why?
|
Case-Control Studies | 7 | 2019 | 22176 | 0.100 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2492 | 0.100 |
Why?
|
Patient Dropouts | 2 | 2012 | 412 | 0.100 |
Why?
|
S-Adenosylhomocysteine | 1 | 2012 | 41 | 0.100 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2012 | 303 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2697 | 0.100 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2013 | 103 | 0.100 |
Why?
|
Life Style | 2 | 2021 | 3917 | 0.100 |
Why?
|
Severity of Illness Index | 10 | 2019 | 15843 | 0.100 |
Why?
|
Integrative Medicine | 1 | 2013 | 87 | 0.100 |
Why?
|
Referral and Consultation | 3 | 2023 | 3600 | 0.100 |
Why?
|
Aminopyridines | 1 | 2015 | 573 | 0.100 |
Why?
|
Cognition Disorders | 3 | 2011 | 3980 | 0.100 |
Why?
|
Acupuncture Points | 1 | 2012 | 111 | 0.100 |
Why?
|
Liver Regeneration | 2 | 1995 | 213 | 0.100 |
Why?
|
Recurrence | 4 | 2020 | 8466 | 0.100 |
Why?
|
Probability | 3 | 2013 | 2477 | 0.100 |
Why?
|
Statistics, Nonparametric | 2 | 2019 | 2850 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 390 | 0.090 |
Why?
|
Universities | 2 | 2015 | 993 | 0.090 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8601 | 0.090 |
Why?
|
Follicle Stimulating Hormone | 1 | 2013 | 726 | 0.090 |
Why?
|
Boston | 3 | 2019 | 9327 | 0.090 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1992 | 436 | 0.090 |
Why?
|
Penile Erection | 1 | 2011 | 100 | 0.090 |
Why?
|
Rhodiola | 1 | 2010 | 3 | 0.090 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2010 | 48 | 0.090 |
Why?
|
Anti-Anxiety Agents | 1 | 2013 | 397 | 0.090 |
Why?
|
Resilience, Psychological | 1 | 2019 | 788 | 0.090 |
Why?
|
Thyrotropin | 1 | 2014 | 834 | 0.090 |
Why?
|
5-Hydroxytryptophan | 1 | 2010 | 32 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2417 | 0.090 |
Why?
|
Light | 1 | 2016 | 1353 | 0.090 |
Why?
|
Hypertension | 2 | 2022 | 8540 | 0.090 |
Why?
|
Lipids | 2 | 2014 | 3341 | 0.090 |
Why?
|
Azabicyclo Compounds | 1 | 2010 | 68 | 0.090 |
Why?
|
Acculturation | 1 | 2012 | 178 | 0.090 |
Why?
|
Liver | 4 | 1995 | 7528 | 0.090 |
Why?
|
Internet | 3 | 2017 | 3093 | 0.090 |
Why?
|
Herbal Medicine | 1 | 2010 | 36 | 0.090 |
Why?
|
Serotonin | 3 | 2023 | 1041 | 0.090 |
Why?
|
Research | 1 | 2018 | 1982 | 0.090 |
Why?
|
Telomerase | 1 | 2015 | 745 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2013 | 1574 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3384 | 0.080 |
Why?
|
Eligibility Determination | 1 | 2013 | 421 | 0.080 |
Why?
|
Chromium | 1 | 2010 | 132 | 0.080 |
Why?
|
Pyrrolidines | 1 | 2011 | 338 | 0.080 |
Why?
|
Purines | 1 | 2013 | 607 | 0.080 |
Why?
|
Inositol | 1 | 2010 | 215 | 0.080 |
Why?
|
Life Change Events | 1 | 2014 | 952 | 0.080 |
Why?
|
Triiodothyronine | 2 | 2014 | 493 | 0.080 |
Why?
|
Dosage Forms | 1 | 2009 | 56 | 0.080 |
Why?
|
Binge-Eating Disorder | 1 | 2010 | 147 | 0.080 |
Why?
|
Bulimia Nervosa | 1 | 2010 | 206 | 0.080 |
Why?
|
Hormones | 2 | 2023 | 869 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1088 | 0.080 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2012 | 294 | 0.080 |
Why?
|
Pain Measurement | 1 | 2018 | 3551 | 0.080 |
Why?
|
Cross-Over Studies | 2 | 2016 | 2079 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2018 | 1388 | 0.080 |
Why?
|
Glycine | 1 | 2011 | 663 | 0.080 |
Why?
|
Cost of Illness | 2 | 2020 | 1937 | 0.080 |
Why?
|
Self Concept | 1 | 2014 | 1045 | 0.080 |
Why?
|
Hydrocortisone | 3 | 2020 | 1819 | 0.080 |
Why?
|
Fatigue | 1 | 2015 | 1552 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2009 | 274 | 0.070 |
Why?
|
Violence | 1 | 2014 | 937 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3358 | 0.070 |
Why?
|
Personal Autonomy | 1 | 2010 | 304 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2008 | 353 | 0.070 |
Why?
|
Social Adjustment | 1 | 2010 | 632 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2022 | 4016 | 0.070 |
Why?
|
Perceptual Distortion | 1 | 2007 | 36 | 0.070 |
Why?
|
Prolactin | 2 | 2013 | 625 | 0.070 |
Why?
|
Pregnancy | 6 | 2023 | 29890 | 0.070 |
Why?
|
Models, Statistical | 2 | 2012 | 5079 | 0.070 |
Why?
|
Transforming Growth Factor beta | 3 | 1995 | 1964 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2012 | 1702 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6391 | 0.070 |
Why?
|
Neurotransmitter Agents | 1 | 2010 | 665 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1667 | 0.070 |
Why?
|
Exercise Therapy | 1 | 2013 | 929 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20100 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.070 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2024 | 58984 | 0.060 |
Why?
|
Quinolines | 1 | 2011 | 765 | 0.060 |
Why?
|
Attitude to Health | 2 | 2013 | 2025 | 0.060 |
Why?
|
Advisory Committees | 1 | 2010 | 787 | 0.060 |
Why?
|
Evidence-Based Medicine | 2 | 2019 | 3688 | 0.060 |
Why?
|
Child Abuse | 1 | 2014 | 1077 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1250 | 0.060 |
Why?
|
Regression Analysis | 4 | 2014 | 6345 | 0.060 |
Why?
|
Nutrition Surveys | 2 | 2023 | 1733 | 0.060 |
Why?
|
Patient Preference | 1 | 2013 | 927 | 0.060 |
Why?
|
Circadian Rhythm | 1 | 2016 | 2576 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1505 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1875 | 0.060 |
Why?
|
Cholesterol | 2 | 2004 | 2905 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2791 | 0.060 |
Why?
|
Lithium | 3 | 2004 | 596 | 0.060 |
Why?
|
Posterior Cerebral Artery | 1 | 2024 | 35 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 1995 | 5799 | 0.060 |
Why?
|
Polysomnography | 2 | 2022 | 1848 | 0.060 |
Why?
|
Cerebral Arterial Diseases | 1 | 2024 | 82 | 0.060 |
Why?
|
Prospective Studies | 5 | 2019 | 54423 | 0.060 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2023 | 47 | 0.060 |
Why?
|
Philosophy | 1 | 2004 | 68 | 0.060 |
Why?
|
Culture | 3 | 2007 | 623 | 0.050 |
Why?
|
Signal Transduction | 2 | 2024 | 23447 | 0.050 |
Why?
|
Stress, Psychological | 3 | 2014 | 4481 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2024 | 275 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1420 | 0.050 |
Why?
|
Psychoneuroimmunology | 1 | 2022 | 13 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2010 | 1179 | 0.050 |
Why?
|
Euphoria | 1 | 2022 | 65 | 0.050 |
Why?
|
Leukocytes | 2 | 2023 | 2026 | 0.050 |
Why?
|
Postpartum Period | 2 | 2022 | 1175 | 0.050 |
Why?
|
Pirenzepine | 1 | 2002 | 116 | 0.050 |
Why?
|
Research Design | 2 | 2020 | 6180 | 0.050 |
Why?
|
Androgens | 1 | 2009 | 1286 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2014 | 432 | 0.050 |
Why?
|
Social Behavior | 1 | 2008 | 1135 | 0.050 |
Why?
|
Attitude | 1 | 2007 | 775 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 1995 | 9610 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7396 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2023 | 191 | 0.050 |
Why?
|
Anorexia Nervosa | 1 | 2010 | 1361 | 0.050 |
Why?
|
Thiophenes | 1 | 2006 | 569 | 0.050 |
Why?
|
Technology | 1 | 2023 | 292 | 0.050 |
Why?
|
Gyrus Cinguli | 2 | 2020 | 1115 | 0.050 |
Why?
|
Systems Analysis | 1 | 2021 | 169 | 0.050 |
Why?
|
Social Perception | 1 | 2004 | 433 | 0.050 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.050 |
Why?
|
Japan | 2 | 2015 | 1378 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13255 | 0.050 |
Why?
|
Health Surveys | 2 | 2021 | 4061 | 0.050 |
Why?
|
RNA, Messenger | 2 | 1992 | 12794 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2024 | 1096 | 0.040 |
Why?
|
Physician's Role | 1 | 2007 | 917 | 0.040 |
Why?
|
Religion | 1 | 2004 | 372 | 0.040 |
Why?
|
Hyperthermia, Induced | 1 | 2024 | 417 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2000 | 157 | 0.040 |
Why?
|
Data Collection | 2 | 2007 | 3322 | 0.040 |
Why?
|
Neuropsychological Tests | 3 | 2024 | 7054 | 0.040 |
Why?
|
Fatty Acids | 1 | 2008 | 1808 | 0.040 |
Why?
|
GABA Modulators | 1 | 2020 | 109 | 0.040 |
Why?
|
Chronic Disease | 2 | 2020 | 9319 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 80647 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2057 | 0.040 |
Why?
|
Calcium Phosphates | 1 | 2020 | 171 | 0.040 |
Why?
|
Incidence | 4 | 2022 | 21355 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1416 | 0.040 |
Why?
|
Spirituality | 1 | 2004 | 425 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2000 | 367 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 474 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2495 | 0.040 |
Why?
|
Empathy | 1 | 2023 | 473 | 0.040 |
Why?
|
Irritable Mood | 1 | 2020 | 194 | 0.040 |
Why?
|
Psychopathology | 1 | 2021 | 432 | 0.040 |
Why?
|
Ovariectomy | 1 | 2021 | 614 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2007 | 1117 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12973 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1443 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3206 | 0.040 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 439 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1035 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 1995 | 286 | 0.040 |
Why?
|
Zinc | 1 | 2022 | 690 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15936 | 0.040 |
Why?
|
Prescriptions | 1 | 2020 | 386 | 0.040 |
Why?
|
Mood Disorders | 1 | 2004 | 1127 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 29629 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15633 | 0.030 |
Why?
|
Professional Competence | 1 | 2000 | 431 | 0.030 |
Why?
|
Cell Adhesion | 2 | 1994 | 3088 | 0.030 |
Why?
|
Mental Health | 2 | 2018 | 3250 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 540 | 0.030 |
Why?
|
Genetic Markers | 1 | 2023 | 2601 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2004 | 942 | 0.030 |
Why?
|
Delphi Technique | 1 | 2020 | 846 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1380 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.030 |
Why?
|
Color | 1 | 2016 | 299 | 0.030 |
Why?
|
Politics | 1 | 2022 | 815 | 0.030 |
Why?
|
Basement Membrane | 2 | 1994 | 349 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2003 | 1436 | 0.030 |
Why?
|
Child | 6 | 2023 | 80158 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2020 | 741 | 0.030 |
Why?
|
Methylation | 1 | 2018 | 1084 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2015 | 161 | 0.030 |
Why?
|
Dominance, Cerebral | 1 | 2016 | 623 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1336 | 0.030 |
Why?
|
Age Factors | 3 | 2023 | 18399 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 668 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2395 | 0.030 |
Why?
|
G1 Phase | 1 | 1995 | 403 | 0.030 |
Why?
|
Sex Offenses | 1 | 2018 | 352 | 0.030 |
Why?
|
Binding Sites | 1 | 2002 | 6056 | 0.030 |
Why?
|
Desipramine | 2 | 2004 | 182 | 0.030 |
Why?
|
Netherlands | 1 | 2018 | 2221 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2421 | 0.030 |
Why?
|
Curriculum | 1 | 2007 | 3743 | 0.030 |
Why?
|
Sex Distribution | 2 | 2013 | 2280 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1113 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6237 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2018 | 703 | 0.030 |
Why?
|
Body Temperature | 1 | 2016 | 781 | 0.030 |
Why?
|
Exercise | 2 | 2020 | 5890 | 0.030 |
Why?
|
Punishment | 1 | 2014 | 95 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2019 | 3415 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2004 | 7828 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3701 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2426 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1473 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 1992 | 186 | 0.030 |
Why?
|
Cycloheximide | 1 | 1992 | 343 | 0.020 |
Why?
|
Education, Medical | 1 | 2004 | 1725 | 0.020 |
Why?
|
Alcohol Drinking | 2 | 2020 | 4028 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2548 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2022 | 36426 | 0.020 |
Why?
|
Adolescent Psychiatry | 1 | 2013 | 157 | 0.020 |
Why?
|
Clinical Competence | 1 | 2007 | 4793 | 0.020 |
Why?
|
Gels | 1 | 1992 | 420 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2739 | 0.020 |
Why?
|
Melatonin | 1 | 2016 | 669 | 0.020 |
Why?
|
Postmenopause | 1 | 2020 | 2513 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4415 | 0.020 |
Why?
|
Government Regulation | 1 | 2015 | 524 | 0.020 |
Why?
|
Thyroxine | 1 | 2014 | 666 | 0.020 |
Why?
|
Databases, Factual | 2 | 2020 | 7968 | 0.020 |
Why?
|
Child Psychiatry | 1 | 2013 | 228 | 0.020 |
Why?
|
Cells, Cultured | 4 | 1995 | 18966 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 4937 | 0.020 |
Why?
|
Reaction Time | 1 | 2016 | 2089 | 0.020 |
Why?
|
Self Report | 2 | 2012 | 3725 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3124 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2919 | 0.020 |
Why?
|
Rats | 4 | 1995 | 23741 | 0.020 |
Why?
|
Minerals | 1 | 2011 | 283 | 0.020 |
Why?
|
Animals | 8 | 2020 | 168475 | 0.020 |
Why?
|
Health Personnel | 2 | 2004 | 3335 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15266 | 0.020 |
Why?
|
Sex Factors | 2 | 2013 | 10554 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3113 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12990 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2009 | 861 | 0.020 |
Why?
|
Hepatectomy | 1 | 1992 | 557 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
Reference Values | 1 | 2016 | 4920 | 0.020 |
Why?
|
Computer Simulation | 1 | 2022 | 6241 | 0.020 |
Why?
|
Cell Division | 2 | 1994 | 4465 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2020 | 1853 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4125 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 1995 | 8181 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2176 | 0.020 |
Why?
|
Corpus Striatum | 1 | 2014 | 1235 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7237 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2009 | 713 | 0.020 |
Why?
|
Executive Function | 1 | 2016 | 1392 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1814 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.020 |
Why?
|
Constipation | 1 | 2012 | 563 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 841 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1994 | 1726 | 0.020 |
Why?
|
Psychology | 1 | 2008 | 356 | 0.020 |
Why?
|
Estradiol | 1 | 2013 | 1937 | 0.020 |
Why?
|
Attention | 1 | 2016 | 2396 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2461 | 0.020 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 703 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1718 | 0.020 |
Why?
|
Transcription Factors | 2 | 1995 | 12130 | 0.020 |
Why?
|
Mental Recall | 1 | 2011 | 1221 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2382 | 0.010 |
Why?
|
Motivation | 1 | 2014 | 2006 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3514 | 0.010 |
Why?
|
Blood Platelets | 1 | 2014 | 2479 | 0.010 |
Why?
|
Fenfluramine | 1 | 2003 | 58 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3359 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2006 | 675 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12953 | 0.010 |
Why?
|
Endpoint Determination | 1 | 2005 | 590 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2264 | 0.010 |
Why?
|
Trazodone | 1 | 2002 | 68 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9610 | 0.010 |
Why?
|
Long-Term Care | 1 | 2007 | 633 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14608 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5872 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9647 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 324 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1200 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6770 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7213 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 2004 | 397 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3816 | 0.010 |
Why?
|
Brain Mapping | 1 | 2016 | 6635 | 0.010 |
Why?
|
Creatinine | 1 | 2005 | 1899 | 0.010 |
Why?
|
California | 1 | 2004 | 1430 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.010 |
Why?
|
Hospitalization | 1 | 1999 | 10721 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1648 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1992 | 7593 | 0.010 |
Why?
|
China | 1 | 2004 | 2374 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23996 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2002 | 1132 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2002 | 2707 | 0.010 |
Why?
|
Genes, jun | 1 | 1994 | 69 | 0.010 |
Why?
|
Genes, fos | 1 | 1994 | 176 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 11904 | 0.010 |
Why?
|
Genes, myc | 1 | 1994 | 390 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2928 | 0.010 |
Why?
|
Alleles | 1 | 2003 | 6864 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36193 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3251 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42232 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1756 | 0.010 |
Why?
|
Smoking | 1 | 2005 | 9053 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12441 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5790 | 0.000 |
Why?
|
Protein Binding | 1 | 1995 | 9353 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17635 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1994 | 11530 | 0.000 |
Why?
|